JBJeancy Moke Boy

Jeancy Moke Boy

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Jeancy Moke Boy has a total of 6 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Phytochemical Profiling and Exploratory Evaluation of Momordica charantia in a Cadmium-Induced Murine Model of Splenic Injury

    by Jeancy Moke Boy, Jonathan Mpoyi Mukanya, Kevin Kongolo Muamba, Isaac Elaka Kaba, Paulin Kapepula Mutwale, Nadège Kabamba Ngombe, Dieudonné Tshitenge Tshitenge

    Momordica charantia L. is traditionally used for the management of splenomegaly, although empirical evidence supporting this ethnomedical indication remains limited. This study primarily investigated the traditional fresh leaf/stem infusion and, comparatively, related M. charantia preparations in a cadmium chloride (CdCl2)-induced murine model of splenic injury. Ninety-six Swiss mice were allocated to eight groups, with terminal assessments on Days 1, 7, and 9; CdCl2 was administered on Day 4. Splenic outcomes included absolute and relative spleen mass and qualitative histopathology. Phytochemical profiling was performed by ultra-performance liquid chromatography coupled to high-resolution mass spectrometry (UPLC-HRMS), and radical-scavenging activity was assessed using ABTS and DPPH assays. At Day 9, the traditional fresh leaf/stem infusion showed the strongest and most consistent treatment-associated signal, with lower relative and absolute spleen masses than the CdCl2-exposed disease control. Several other preparations showed numerical reductions in absolute spleen mass but did not meet multiplicity-adjusted significance thresholds. UPLC-HRMS revealed diverse features consistent with triterpenoid-, glycoside-, sterol-, and oxygenated lipid-related natural-product classes. These exploratory findings provide experimental support for further investigation of the traditional fresh leaf/stem infusion, while not establishing clinical efficacy against human splenomegaly.